ME 2303

• Description :

  ME 2303 (FAD 104) is a fluoro-pyranosyl adriamycin analogue with anti-tumor potential. ME 2303 can inhibit the proliferation of acute undifferentiated myeloblastic leukemia (AML) blast cells in a dose-dependent manner. ME 2303 can be used for the study of acute undifferentiated myeloblastic leukemia (AML) [1].

• Product Name Alternative :

  FAD 104

• UNSPSC :

  12352005

• Target :

  Others

• Related Pathways :

  Others

• Field of Research :

  Cancer

• Smiles :

  OC1=C2C([C@H](C[C@@](C(COC(CCCCCC(O)=O)=O)=O)(O)C2)O[C@@]3([H])[C@@H]([C@@H]([C@H](O)[C@H](C)O3)O)F)=C(O)C4=C1C(C5=CC=CC(OC)=C5C4=O)=O

• Molecular Formula :

  C34H37FO15

• Molecular Weight :

  704.65

• References & Citations :

  [1]Blazsek I, et al. The differentiation-promoting potential of a cytostatic fluoro-pyranosyl adriamycin analog (FAD 104) . Biomed Pharmacother. 1989;43 (4) :267-70.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  Phase 2

• CAS Number :

  [116521-53-0]